The pharmacovigilance landscape is evolving substantially with the changing regulatory environment and compliance requirements. With the increase in the number of drugs being approved by major regulatory authorities globally, and increased awareness, social media connectivity and media scrutiny, the pharmaceutical companies would be required to conduct surveillance of drug-related adverse events more efficiently than ever.
This webinar details how organizations can counter these challenges and become more sophisticated in their drug-related adverse event reporting by adopting state-of-the-art cognitive computing processes into their existing pharmacovigilance management systems. It addresses how cognitive computing technologies can automate a multitude of tasks in pharmacovigilance, thereby significantly increasing productivity, reducing adverse event case-processing time and reducing overall expense, and improving compliance.
Featured Topics:
- Scope of automation in pharmacovigilance
- Application of cognitive computing technologies in case processing, including data entry, medical review and literature surveillance
- How pharmacovigilance systems can help achieve compliance with changing regulations
- Understanding the expected productivity gains with the adoption of newer technologies in pharmacovigilance
- Quality of case processing can be much better using cognitive computing and robotic process automation
[contact-form-7 id=”10062″ title=”Contact form for webinar”]
ArisGlobal Launches LifeSphere NavaX™ 
